Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion.
Saved in:
| Title: | Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion. |
|---|---|
| Authors: | Villodre ES; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hu X; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Larson R; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Finetti P; Laboratory of Predictive Oncology, Aix-Marseille University, Inserm, CNRS, Institut Paoli-Calmettes, CRCM, Marseille, France., Gomez K; Department of Biological Sciences, The University of Texas at Brownsville, TX, USA., Balema W; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Stecklein SR; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Santiago-Sanchez G; Department Biochemistry and Cancer Center, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico., Krishnamurthy S; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Song J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Su X; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ueno NT; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tripathy D; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Van Laere S; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Belgium., Bertucci F; Laboratory of Predictive Oncology, Aix-Marseille University, Inserm, CNRS, Institut Paoli-Calmettes, CRCM, Marseille, France., Vivas-Mejía P; Department Biochemistry and Cancer Center, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico., Woodward WA; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Debeb BG; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. |
| Source: | Molecular oncology [Mol Oncol] 2021 Oct; Vol. 15 (10), pp. 2752-2765. Date of Electronic Publication: 2021 Aug 27. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34342930 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Villodre+ES%22">Villodre ES</searchLink>; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Hu+X%22">Hu X</searchLink>; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Larson+R%22">Larson R</searchLink>; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Finetti+P%22">Finetti P</searchLink>; Laboratory of Predictive Oncology, Aix-Marseille University, Inserm, CNRS, Institut Paoli-Calmettes, CRCM, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Gomez+K%22">Gomez K</searchLink>; Department of Biological Sciences, The University of Texas at Brownsville, TX, USA.<br /><searchLink fieldCode="AU" term="%22Balema+W%22">Balema W</searchLink>; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Stecklein+SR%22">Stecklein SR</searchLink>; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Santiago-Sanchez+G%22">Santiago-Sanchez G</searchLink>; Department Biochemistry and Cancer Center, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico.<br /><searchLink fieldCode="AU" term="%22Krishnamurthy+S%22">Krishnamurthy S</searchLink>; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Song+J%22">Song J</searchLink>; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Su+X%22">Su X</searchLink>; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Ueno+NT%22">Ueno NT</searchLink>; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Tripathy+D%22">Tripathy D</searchLink>; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Van+Laere+S%22">Van Laere S</searchLink>; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Belgium.<br /><searchLink fieldCode="AU" term="%22Bertucci+F%22">Bertucci F</searchLink>; Laboratory of Predictive Oncology, Aix-Marseille University, Inserm, CNRS, Institut Paoli-Calmettes, CRCM, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Vivas-Mejía+P%22">Vivas-Mejía P</searchLink>; Department Biochemistry and Cancer Center, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico.<br /><searchLink fieldCode="AU" term="%22Woodward+WA%22">Woodward WA</searchLink>; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Debeb+BG%22">Debeb BG</searchLink>; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101308230%22">Molecular oncology</searchLink> [Mol Oncol] 2021 Oct; Vol. 15 (10), pp. 2752-2765. <i>Date of Electronic Publication: </i>2021 Aug 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons%2C+Inc%22">John Wiley & Sons, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101308230 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1878-0261 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215747891%22">15747891 </searchLink><i>NLM ISO Abbreviation: </i>Mol Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34342930 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/1878-0261.13074 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2752 Titles: – TitleFull: Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Villodre ES – PersonEntity: Name: NameFull: Hu X – PersonEntity: Name: NameFull: Larson R – PersonEntity: Name: NameFull: Finetti P – PersonEntity: Name: NameFull: Gomez K – PersonEntity: Name: NameFull: Balema W – PersonEntity: Name: NameFull: Stecklein SR – PersonEntity: Name: NameFull: Santiago-Sanchez G – PersonEntity: Name: NameFull: Krishnamurthy S – PersonEntity: Name: NameFull: Song J – PersonEntity: Name: NameFull: Su X – PersonEntity: Name: NameFull: Ueno NT – PersonEntity: Name: NameFull: Tripathy D – PersonEntity: Name: NameFull: Van Laere S – PersonEntity: Name: NameFull: Bertucci F – PersonEntity: Name: NameFull: Vivas-Mejía P – PersonEntity: Name: NameFull: Woodward WA – PersonEntity: Name: NameFull: Debeb BG IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2021 Oct Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1878-0261 Numbering: – Type: volume Value: 15 – Type: issue Value: 10 Titles: – TitleFull: Molecular oncology Type: main |
| ResultId | 1 |
